Priority at the European Patent Office
Yesterday, in a high-profile case relating to CRISPR technology, the EPO confirmed its practice regarding the validity of priority claims.
US China Trade Deal
The trade deal signed this week between the US and China is interesting from an Intellectual Property perspective.
Regen Lab v Estar Medical
Following the Supreme Court’s decision in Actavis V Eli Lilly and the first application of the reformed Improver questions for infringement in Icescape v Ice-world, a further judgement from HH Judge Hacon has provided a second example of the test bei
EPO and Patents Court decisions clash in patent validity dispute.
English Patents Court* grants Novartis a preliminary injunction against generics company Dr Reddy’s in respect of patented breast cancer drug, providing a provisional validity opinion that is inconsistent with co-pending opposition proceedings at the
No direction on the issue of direct infringement for Swiss-form claims
Beyond the matter of sufficiency in the Warner-Lambert pregabalin case, the UK Supreme Court unanimously decided that there would have been no infringement had the claims in question been valid.
Pregabalin patent – Supreme Court finds the patent bargain broken
The United Kingdom Supreme Court today (14 November 2018) handed down a significant patent decision[i] relating to the degree to which a patentee must demonstrate an invention at the time of making the application.
Court backs Broad over Berkeley in CRISPR patent battle
On 10 September 2018, the United States Court of Appeals for the Federal Circuit upheld a judgment from interference proceedings at the US Patent and Trademark Office (USPTO).
Patient capital investment fund to benefit UK start-ups to the tune of £2.5 billion
UK-based start-ups have received a boost from the news that the British Business Bank is establishing a programme worth £2.5 billion to assist new businesses to move to the next stage in their growth and development.
UK patent attorney to help Serbian medical researchers bring their innovations to doctors and patients around the world
A UK-based patent attorney will travel to Serbia next week to assist medical researchers in the country in bringing their findings out of the lab and into use on hospital wards around the world.